The Rise of GLP-1 Drugs and Their Impact on Beauty Sales
The popularity of GLP-1 drugs, which are used for weight loss, has led to a surge in demand for beauty products that address their side effects. This trend is being closely watched by industry leaders, with Ulta Beauty’s CEO highlighting the growing interest in anti-hairfall treatments and skin elasticity products.
According to Kecia Steelman, the CEO of Ulta Beauty, there is a noticeable increase in customers seeking solutions for hair loss and skin issues associated with these medications. “Hair loss with GLP-1s is real, and products that can help with that,” she said in an interview with Yahoo Finance’s Opening Bid. “And then also skin elasticity, when you’re losing weight really rapidly, you know, the skin elasticity is something that you’ve got to get moisture into.”
This trend has created a crossover between two distinct groups: those using GLP-1 drugs and individuals experiencing signs of aging. Both groups are looking for products that can help maintain their appearance and “the longevity of the look.”
Understanding GLP-1 Drugs
GLP-1 drugs, such as Ozempic and Wegovy, have gained significant traction in the United States. An estimated 10% of the population is currently taking some form of weight-loss drug. These medications work by mimicking the hormone glucagon-like peptide-1, which helps regulate appetite and blood sugar levels.
However, they come with potential side effects, including hair loss and changes in skin texture. In clinical trials for Wegovy, hair loss was reported as a side effect in 3% of participants. This has prompted many users to seek out additional products to manage these effects.
Other Companies Capitalizing on the Trend
The impact of GLP-1 drugs extends beyond Ulta Beauty. Other companies are also capitalizing on the “Ozempic face” phenomenon, which refers to the sunken or gaunt appearance some users experience after rapid weight loss.
In 2024, the CEO of Swiss pharmaceutical giant Galderma told Bloomberg that there is a strong demand for facial fillers to counteract this look. This trend highlights how the beauty industry is adapting to the changing needs of consumers.
Broader Impacts of Weight-Loss Drugs
The effects of weight-loss drugs are not limited to the beauty sector. Tailors on Wall Street have reported that their clients have brought back entire wardrobes to be taken in, as clothing sizes shrink with weight loss. This has created a ripple effect across various industries, from fashion to healthcare.
Ulta Beauty has seen significant growth in sales, reporting annual sales of about $12.39 billion in 2025, a 11.8% increase from the previous year. Skincare, wellness, and hair care accounted for 43% of its total sales, indicating a strong focus on these areas.
Financial Performance and Market Response
The company’s stock price has risen about 50% in the past year, reflecting investor confidence in its ability to navigate the changing market landscape. This growth underscores the importance of adapting to consumer trends and addressing their evolving needs.
As the popularity of GLP-1 drugs continues to rise, it is likely that the beauty and wellness industries will see further shifts in product demand and innovation. Companies that can effectively respond to these changes will be well-positioned to thrive in this dynamic market.
